Callan JMB Received Notice of Delisting

Nasdaq notified Callan JMB (CJMB) of delisting due to insufficient stockholders' equity. The company requested a hearing, which temporarily halts trading suspension. Success of the appeal is uncertain.

Original reporting
Published Oct 16, 2026, 8:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Callan JMB Received Notice of Delisting — source image
Decision brief

The 30-second read

$CJMBBearishMed
01

Why it matters

The notice signals a high probability of trading suspension, which can trigger rapid price declines and liquidity issues.

02

Market read

The primary trading relevance is the potential loss of listing and associated price pressure for CJMB.

03

What to watch

Potential for a private placement or merger that could restore compliance and preserve listing.

Relevance 6/10Novelty 7/10Timing: pre‑market today

Background

Delisting notices are issued when a listed company fails to meet Nasdaq's equity or other listing standards.

Company-level read

Ticker impact

$CJMBBearishHigh confidence
Context

Nasdaq issued a delisting notice after the company failed to meet the $2.5M stockholders' equity requirement.

Expected impact

likely pressure as investors price in potential suspension and loss of liquidity

Evidence & confidence

A delisting determination is a material corporate action that typically triggers sell‑offs, especially for a micro‑cap with limited alternatives.

Market effects

Minimal sector impact; primarily affects the company's own trading dynamics.

Limited to investors holding the micro‑cap; no broader regional effect.

Low global relevance.

Counterpoint

If the company successfully appeals the delisting, the stock could rebound on short‑covering.

Key entities

  • Callan JMB Inc.

    Issuer of the delisting notice.

  • Nasdaq

    Regulatory body issuing the delisting determination.

Related articles

$CJMBMedAI 8/10

Callan JMB (CJMB) Stock Rallies 50% After Hours: Here's Why it is Trending - Callan Jmb (NASDAQ:CJMB)

Callan JMB Inc. (NASDAQ:CJMB) shares rose about 49.8% to $1.29 after hours after the company said it signed a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem. Callan will provide logistics and regulatory support and receive 21% of qualifying gross revenue. Management projected annual gross revenues near $500 million, about $105 million for the company. The stock also faces a Nasdaq $1 bid compliance deadline.